Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock, Par Value $0.0001 Per Share
-
Shares outstanding
-
23,267,064
-
Number of holders
-
135
-
Total 13F shares, excl. options
-
12,210,439
-
Shares change
-
-136,319
-
Total reported value, excl. options
-
$1,427,893,568
-
Value change
-
-$10,189,929
-
Put/Call ratio
-
44.06%
-
Number of buys
-
66
-
Number of sells
-
-53
-
Price
-
$116.97
Significant Holders of MADRIGAL PHARMACEUTICALS, INC. - Common Stock, Par Value $0.0001 Per Share (MDGL) as of Q1 2021
164 filings reported holding MDGL - MADRIGAL PHARMACEUTICALS, INC. - Common Stock, Par Value $0.0001 Per Share as of Q1 2021.
MADRIGAL PHARMACEUTICALS, INC. - Common Stock, Par Value $0.0001 Per Share (MDGL) has 135 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12,210,439 shares
of 23,267,064 outstanding shares and own 52.48% of the company stock.
Largest 10 shareholders include Capital Research Global Investors (1,893,066 shares), BAKER BROS. ADVISORS LP (1,499,213 shares), Avoro Capital Advisors LLC (1,425,000 shares), VANGUARD GROUP INC (997,809 shares), BlackRock Inc. (956,096 shares), WELLINGTON MANAGEMENT GROUP LLP (816,834 shares), STATE STREET CORP (585,750 shares), ARMISTICE CAPITAL, LLC (350,000 shares), MORGAN STANLEY (262,894 shares), and Rock Springs Capital Management LP (258,500 shares).
This table shows the top 135 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.